What We're Reading: Page 89
Industry reads hand-picked by our editors
Sep 22, 2023
Sep 21, 2023
-
STAT News
They carry a gene for ALS but aren’t sick. What does medical research owe them?
-
Bloomberg Law
Drugmakers Aren’t Waiting Around for Details on Medicare Tax
-
Reuters
India’s Glenmark to sell majority stake in life sciences unit for $680 million
-
MIT Technology Review
DeepMind is using AI to pinpoint the causes of genetic disease
Sep 20, 2023
-
Reuters
U.S. FDA found lapses at Novo’s main U.S. factory in May 2022
-
NBC News
FDA rejects first needle-free alternative to EpiPens, calling for additional research
-
The New York Times
How Much Do Patients Need to Know About a Potentially Risky Treatment?
-
The Washington Post
Inside the gold rush to sell cheaper imitations of Ozempic
Sep 19, 2023
-
Wired
Crispr Pioneer Jennifer Doudna Has the Guts to Take On the Microbiome
-
The Washington Post
How one company profited while delaying Narcan’s drugstore debut
-
Nature
AI can help to speed up drug discovery — but only if we give it the right data
-
The Wall Street Journal
Bankrupt Drugmaker Mallinckrodt Considers Sale of Opioid Business
Sep 18, 2023
Sep 15, 2023
-
Reuters
Bayer’s new CEO plans to cut management jobs in prelude to overhaul
-
Bloomberg
Covid Vaccine Maker Moderna Faces Tougher Competition
-
Fierce Biotech
FDA resource constraints delay decision on Iovance cell therapy
-
AP News
Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval
Sep 14, 2023
-
Nature
‘A Pandora’s box’: map of protein-structure families delights scientists
-
The New York Times
The Stock Market Hopes Arm’s IPO Is a Hit
-
Fierce Biotech
AbbVie drops Harpoon’s BCMA drug, ending dream of $200M payday
-
MIT Technology Review
She was a semi-pro Go player but learned that biology is even harder
Previous
